Position
DMC Group, LLC in BridgeBio Pharma, Inc.
Back to the book · All holders of BBIO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$7.8K$76.49 → $74.26
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.5K | $267.7K | — | — | — | 0.2% |
| Q1 2026 | 3.5K | $259.9K | $74.26 | −$7.8K | −$0 | 0.2% |